Construction of a combinatorial library of chimeric tumor-specific promoters

Kirill N Kashkin1, Igor P Chernov1, Dmitry A Didych1

  • 1Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.

Biotechniques
|September 16, 2017
PubMed

Insights

Researchers developed a novel method to create a library of gene promoters for cancer therapy. This combinatorial approach successfully identified highly active and tumor-specific promoters, advancing gene therapy research.

Area of Science:

  • Molecular Medicine
  • Oncology
  • Biotechnology

Background:

  • Gene therapy holds significant promise for cancer treatment, but requires effective, cancer-specific promoters for targeted gene expression.
  • The development of novel promoters is crucial for enhancing the efficacy and safety of therapeutic gene delivery in oncology.

Purpose of the Study:

  • To create a combinatorial library of tumor-specific chimeric promoter modules to identify novel promoters with desired functions for cancer gene therapy.
  • To establish a robust platform for selecting highly specific and effective promoters for therapeutic applications.

Main Methods:

  • A combinatorial library was constructed by randomly combining promoter fragments from eight human cell proliferation control genes.
  • Chimeric promoters were inserted into a lentiviral vector upstream of a reporter gene (CopGFP) and transduced into A431 cells.
  • Active promoters were enriched using cell sorting, followed by analysis of the enriched library.

Main Results:

  • The combinatorial library approach yielded a high proportion of active promoters.
  • A significant number of tumor-specific promoters were identified within the enriched library.
  • The method demonstrated effectiveness in selecting promoters with desired functional characteristics.

Conclusions:

  • The combinatorial library of chimeric promoters is a valuable tool for discovering and selecting highly specific and effective promoters for cancer research.
  • This approach facilitates the advancement of gene therapy by providing researchers with optimized regulatory elements for targeted gene expression.
  • The methodology offers a scalable and efficient strategy for promoter discovery in molecular medicine and oncology.